id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
S8961 R30349 |
Christensen (Lamotrigine) (Controls unexposed NOS) (Mixed indications), 2015 | Low Apgar score (≤ 7) at 5 min | during pregnancy (anytime or not specified) | population based cohort propective | unexposed (general population or NOS) excluded | Adjustment: No |
0.88 [0.47;1.62] excluded (control group) |
10/875 8,797/674,115 | 8,807 | 875 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S8962 R30350 |
Christensen (Lamotrigine) (Controls unexposed, sick) (Mixed indications), 2015 | Low Apgar score (≤ 7) at 5 min | during pregnancy (anytime or not specified) | population based cohort propective | unexposed, sick | Adjustment: No | 0.90 [0.46;1.75] C | 10/875 67/5,261 | 77 | 875 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S8902 R30058 |
Artama (Lamotrigine) (Controls unexposed, disease free), 2013 | 5-min Apgar <7 | 3rd trimester | population based cohort retrospective | unexposed, disease free excluded | Adjustment: Yes |
1.69 [0.53;5.36] excluded (control group) |
3/132 3,014/269,151 | 3,017 | 132 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S8903 R30070 |
Artama (Lamotrigine) (Controls unexposed, sick), 2013 | 5-min Apgar <7 | 3rd trimester | population based cohort retrospective | unexposed, sick | Adjustment: Yes | 1.89 [0.46;7.76] | 3/132 3/652 | 6 | 132 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S8953 R30310 |
Veiby (Lamotrigine) (Controls unexposed, disease free) b, 2013 | Low Apgar score (< 7 at 5 min) | during pregnancy (anytime or not specified) | prospective cohort | unexposed, disease free excluded | Adjustment: No |
1.20 [0.30;4.80] excluded (control group) |
2/103 1,710/106,899 | 1,712 | 103 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S8954 R30324 |
Veiby (Lamotrigine) (Controls unexposed, sick) b, 2013 | Low Apgar score (< 7 at 5 min) | during pregnancy (anytime or not specified) | prospective cohort | unexposed, sick | Adjustment: No | 0.83 [0.18;3.90] C | 2/103 9/386 | 11 | 103 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S8957 R30338 |
Borthen (Lamotrigine) (Controls unexposed, disease free), 2010 | Apgar < 7 after 5 minutes | during pregnancy (anytime or not specified) | population based cohort retrospective | unexposed, disease free excluded | Adjustment: Yes |
1.90 [0.90;4.00] excluded (control group) |
7/233 6,022/362,302 | 6,029 | 233 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S8959 R30346 |
Borthen (Lamotrigine) (Controls unexposed, sick), 2010 | Apgar < 7 after 5 minutes | during pregnancy (anytime or not specified) | population based cohort retrospective | unexposed, sick | Adjustment: No | 1.89 [0.82;4.36] C | 7/233 30/1,863 | 37 | 233 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | 4 studies | 1.22 [0.76;1.94] | 131 | 1,343 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives |
1: Lamotrigine) (Controls unexposed, sick) (Mixed indications; 2: Lamotrigine) (Controls unexposed, sick; 3: Lamotrigine) (Controls unexposed, sick) ; 4: Lamotrigine) (Controls unexposed, sick;
Asymetry test p-value = NaN (by Egger's regression)
not enought points
excluded 8957, 8902, 8953, 8961